A Multi-centre, Multinational, Prospective Observational Registry to Collect Safety and Outcome Data in Patients Diagnosed With Severe Hepatic VOD Following Hematopoietic Stem Cell Transplantation (HSCT) and Treated With Defitelio® or Supportive Care (Control Group)

Trial Profile

A Multi-centre, Multinational, Prospective Observational Registry to Collect Safety and Outcome Data in Patients Diagnosed With Severe Hepatic VOD Following Hematopoietic Stem Cell Transplantation (HSCT) and Treated With Defitelio® or Supportive Care (Control Group)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 Feb 2017

At a glance

  • Drugs Defibrotide (Primary)
  • Indications Veno-occlusive disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top